Fate Therapeutics Inc
(NAS:FATE)
$
2.565
+0.050 (+1.98%)
Market Cap: 307.34 Mil
Enterprise Value: 229.25 Mil
PE Ratio: 0
PB Ratio: 1.95
GF Score: 33/100 Fate Therapeutics Inc (FATE) Transcripts
- 1